News
A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis patients. Experts weigh in on the findings.
This combination of initial signs is termed a clinically isolated syndrome (CIS), although CIS does not always convert to MS. The risk factors for relapse (conversion to clinically definite MS ...
Hosted on MSN15d
Vitamin D Could Be an Effective Way to Slow Progress of MSSo researchers conducted a trial with 303 participants diagnosed with clinically isolated syndrome (CIS); a condition that is in some ways similar to, and often develops into, MS. Giving just over ...
Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...
A. Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group. Expert Opin. Pharmacother. 11, 1225–1230 (2010).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results